Bevacizumab Intravenous and Mycophenolate sodium
Determining the interaction of Bevacizumab Intravenous and Mycophenolate sodium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: Bevacizumab
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolic acid, Mycophenolate Tablets Delayed Release
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bevacizumab Intravenous-Mycophenolate Suspension
- Bevacizumab Intravenous-Mycophenolate Tablets
- Bevacizumab Intravenous-Mycophenolate Tablets Delayed Release
- Bevacizumab Intravenous-Mycophenolic acid
- Bevacizumab Intravenous-Mycophenolic Acid Delayed-Release Tablets
- Bevacizumab Intravenous-Mycophenolic Acid Tablets
- Mycophenolate sodium-Bevacizumab-awwb
- Mycophenolate sodium-Bevacizumab-awwb Intravenous
- Mycophenolate sodium-Bevespi Aerosphere
- Mycophenolate sodium-Bevyxxa
- Mycophenolate sodium-Bexarotene
- Mycophenolate sodium-Bexarotene (Systemic)